SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-102378
Filing Date
2010-05-03
Accepted
2010-04-30 17:49:04
Documents
5
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 653760
2 STOCK PURCHASE AGREEMENT dex101.htm EX-10.1 995293
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A)/15D-14(A) dex311.htm EX-31.1 7929
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A)/15D-14(A) dex312.htm EX-31.2 8026
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 3166
  Complete submission text file 0001193125-10-102378.txt   1669552
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 10789133
SIC: 2834 Pharmaceutical Preparations